Why Black Men Face a Higher Prostate Cancer Burden—and Why Race Is Only Part of the Story

• By Andres F. Correa, MD, Associate Professor and Director of Research, Department of Urology

  Black men face the highest prostate cancer burden in the United States. They are more likely to get the disease. It often appears at a younger age. Black men are also more than twice as likely to die from it as other men.

  There is no single reason for this gap. Biology may play a role. So can family history, access to screening, delays in care, insurance, trust, and the place where a person lives. Good care must look at the whole picture.

  Race and Ancestry Are Not the Same Thing

  Race is a broad social label. Ancestry describes a person’s genetic roots. It can vary a great deal among people of the same race. Two Black men may have very different family histories, health risks, and life experiences.

  Treatment should never be chosen by race alone. We use the cancer stage, grade, PSA, scans, biopsy results, gene changes, health, and the patient’s goals.

  What Fox Chase Researchers Are Studying

  Fox Chase researchers recently studied how prostate cancer drugs worked in cell lines from patients with different ancestries. Some drugs worked differently across the models. One of the cell lines came from an Afro-Caribbean patient, a group that has often been missing from prostate cancer research.

  This work is early. It was done in lab models, not in patients. It does not mean doctors should choose a drug by race or ancestry today. It does show why research must include people from many backgrounds. The same drug may not affect every tumor in the same way.

  Other Fox Chase research has looked at neighborhood and social factors linked with aggressive prostate cancer. Poverty, access to care, environmental exposures, and other local conditions can shape when cancer is found and what care a patient receives.

  Earlier Conversations Can Matter

  Prostate cancer often has no early symptoms. Screening can find some higher-risk cancers before they spread. But PSA testing has limits. A high PSA does not always mean cancer. Some prostate cancers may never cause harm.

  Black men should often start the screening talk earlier than men at average risk. Family history also matters. A father, brother, or son with prostate cancer can raise risk. Some gene changes are linked with more serious disease.

  Men with a strong family history or other risk factors can learn more about the Prostate Cancer Risk Assessment Program at Fox Chase.

  What Better Prostate Cancer Care Looks Like

  Closing the gap will take more than a PSA test. Care must be easier to reach. Doctors must listen, share decisions, include more groups in research, and explain every reasonable option.

  It also means avoiding assumptions. Not every Black man has the same risk. Not every elevated PSA needs a biopsy. Not every prostate cancer needs immediate treatment. And no treatment should be selected based on race alone.

  At Fox Chase, prostate cancer specialists review diagnosis, treatment, inherited risk, clinical trials, and quality-of-life goals as part of one plan.

  The Most Important Next Step

  Know your family history and talk with a doctor about your risk. Get answers if your PSA is high, your exam is not normal, or prostate cancer runs in your family.

  The goal is not to create fear. It is to find the men who need closer testing or treatment while helping others avoid care they do not need.

  To speak with a Fox Chase prostate cancer specialist or risk assessment team, request an appointment or call 888-FOX-CHASE (888-369-2427).